Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
Frater J. et al, (2021), The Lancet HIV, 8, e474 - e485
Levels of Human Immunodeficiency Virus DNA Are Determined Before ART Initiation and Linked to CD8 T-Cell Activation and Memory Expansion.
Martin GE. et al, (2020), The Journal of infectious diseases, 221, 1135 - 1145
Virological remission after antiretroviral therapy interruption in female African HIV seroconverters
Gossez M. et al, (2019), AIDS, 33, 185 - 197
The impact of immunoglobulin in acute HIV infection on the HIV reservoir: a randomized controlled trial
Tiraboschi J. et al, (2017), HIV Medicine, 18, 777 - 781
Early antiretroviral therapy reduces HIV DNA following perinatal HIV infection
Foster C. et al, (2017), AIDS, 31, 1847 - 1851
Early antiretroviral therapy reduces HIV DNA following perinatal HIV infection
Foster C. et al, (2017), AIDS, 31, 1847 - 1851
Parallel NextGen full length HIV proviral DNA sequence and integration site analysis
Jones M. et al, (2017), HIV MEDICINE, 18, 23 - 23
Short Communication: Lack of Effect of Maraviroc Intensification on Blood and Gut Reservoir
Tiraboschi J. et al, (2017), AIDS Research and Human Retroviruses, 33, 143 - 146
The impact of immunoglobulin in acute HIV infection on the HIV reservoir: a randomized controlled trial
Tiraboschi J. et al, (2017), HIV MEDICINE, 18, 777 - 781
Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection
Hoffmann M. et al, (2016), PLOS Pathogens, 12, e1005661 - e1005661
Exhaustion of activated CD8 T cells predicts disease progression in primary HIV-1 infection
Martin GE. et al, (2016), JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 19
The effect of Maraviroc intensification on gut reservoir and immune function in HIV-1-infected individuals receiving antiretroviral therapy with suboptimal CD4+T cell recovery
Tiraboschi J. et al, (2016), HIV MEDICINE, 17, 19 - 19
Tenofovir Disoproxil Fumarate Fails to Prevent HIV Acquisition or the Establishment of a Viral Reservoir: Two Case Reports
Fox J. et al, (2016), Infectious Diseases and Therapy, 5, 65 - 71
Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
Hurst J. et al, (2015), Nature Communications, 6
Dynamics of immunoglobulin sequence diversity in HIV-1 infected individuals
Hoehn KB. et al, (2015), Philosophical Transactions of the Royal Society B: Biological Sciences, 370, 20140241 - 20140241
Structured Observations Reveal Slow HIV-1 CTL Escape
Roberts HE. et al, (2015), PLOS Genetics, 11, e1004914 - e1004914
Failure of daily tenofovir to prevent HIV transmission or the establishment of a significant viral reservoir despite continued antiretroviral therapy
Davies O. et al, (2014), Journal of the International AIDS Society, 17, 19731 - 19731
HIV-1 DNA predicts disease progression and post-treatment virological control
Williams JP. et al, (2014), eLife, 3
HIV-1-specific CD4 + responses in primary HIV-1 infection predict disease progression
Frater J. et al, (2014), AIDS, 28, 699 - 708
Longitudinal analysis of an HLA-B*51-restricted epitope in integrase reveals immune escape in early HIV-1 infection
Yager N. et al, (2013), AIDS, 27, 313 - 323